Philips Announces CX50 xMATRIX

Royal Philips ElectronicsRoyal Philips Electronics (AEX: PHI, NYSE: PHG) announced the new CX50 xMATRIX, the world's first portable ultrasound to offer Philips' industry leading Live 3D TEE. Previously only available with Philips iE33 xMATRIX premium echocardiography solution, Live 3D TEE enables 3D visualization of the cardiac structure and function as well as new perspectives of the heart in real time, enabling better patient care.

Since its launch in 2008, Philips CX50 CompactXtreme ultrasound system has been providing the flexibility of a portable system, while delivering the imaging performance of a premium ultrasound solution. With Live 3D TEE now available on the CX50 xMATRIX, interventional teams can more easily access important clinical information and visualizations for complex interventional procedures. For clinical efficiency the compact Live 3D TEE transducer is designed to be shared between the CX50 and iE33 xMATRIX systems. Because of this, departments should be able to reduce the number of TEE transducers that must be purchased, tracked, cleaned, and stored.

"The first thing the staff noticed was the incredibly small size of the CX50 system, which is very useful in our cath lab where space is at a premium," said Dr. David Liang, MD, PhD, Associate Professor of Medicine and Director, Marfan Syndrome and Aortic Disorders at Stanford University. "In clinical evaluations the Live 3D TEE image quality is excellent and, with the new user interface, 3D imaging is really intuitive. In imaging TAVR procedures with the CX50, I am able to easily switch back and forth between 2D and 3D during the critical time when we are positioning the valve."

The CX50 xMATRIX is a uniquely powerful all-in-one imaging solution for structural heart disease (SHD) repairs in cath labs and hybrid cardiac operating rooms, offering Live 3D TEE plus an architecture designed to support future capabilities including advanced fluoro integration (EchoNavigator, 510(k) pending) with Philips Allura systems.

Along with the new CX50 xMATRIX, Philips announced the Vision 2013 upgrade for existing CX50 cardiology customers. Vision 2013 includes:

  • Qlab 9.0 with improved speckle tracking algorithm for faster, more robust strain quantification
  • Available C8-5 and L12-5 50mm transducers for specialized vascular imaging requirements.
  • Available S12-4 and S8-3 sector transducers for pediatric and neonatal imaging.
  • New pediatric analysis and structured reporting capabilities.
  • Vascular structured reporting.
  • Improved annotations and workflow

"We re-engineered the CX50 in order to continue to push the envelope. The CX50 xMATRIX demonstrates our continued commitment to cardiology leadership and to delivering the most clinically relevant echocardiography solutions," said Conrad Smits, CEO Ultrasound, for Philips Healthcare. "The new CX50 xMATRIX is a versatile system that provides hospitals with high quality portable imaging to promote better patient care."

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...